Mesoblast | MSB - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Avita Medical AUD 19.54M 516K 2026-06
Clinuvel Pharmaceuticals AUD 3.85M 5.27M 2025-12
Cochlear AUD 449.4M 214.45M 2025-12
CSL USD 1.23B 498M 2025-12
Pacific Edge NZD 16.75M 2.42M 2026-06
PYC Therapeutics AUD 328.4K 1.8M 2025-12
Ramsay Health Care AUD 5.29B 3.2M 2024-12
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Starpharma Holdings AUD 4.42M 2.86M 2025-12
Telix Pharmaceuticals AUD 107.02M 13.54M 2026-06